Latest Anthrax Stories
ANNAPOLIS, Md., June 4, 2014 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP) announced today that new data from its SparVax(®) anthrax vaccine program were recently presented at the 2014 U.S.
ANNAPOLIS, Md., May 29, 2014 /PRNewswire/ -- PharmAthene, Inc.
With as much money that is being exchanged on a daily basis it may concern most people to know that they are not only transferring paper from one hand to the other, but potentially thousands of microbes.
Appoints Larry Gyenes, Formerly of Columbia Laboratories, as Chief Financial Officer PINE BROOK, N.J., April 8, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc.
ANNAPOLIS, Md., April 7, 2014 /PRNewswire/ -- PharmAthene, Inc.
ANNAPOLIS, Md., April 1, 2014 /PRNewswire/ -- PharmAthene, Inc.
PINE BROOK, N.J., March 10, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc.
A new naming system proposed by one Virginia Tech scientist proposes moving beyond the current biological naming system and supplementing it with a new classification method based on an organism’s genome sequence.
Over 400 subjects participating in phase 3 studies PINE BROOK, N.J., Feb. 5, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc.
Grime Busters and Amazing! NOK OUT™ is on a mission to educate consumers and eradicate disease-causing organisms.
Bacillus anthracis is a Gram-positive spore-forming, rod-shaped bacterium, with a width of 1-1.2Âµm and a length of 3-5Âµm. It can grow in aerobic or anaerobic conditions. It is the only known bacterium to synthesize a protein capsule and the only pathogenic bacterium to carry its own adenylyl cyclase virulence factor. They form oval spores located centrally in a non-swollen sporangium. These spores are highly resilient and can survive extreme temperatures, low-nutrient environments, and...
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.